Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT

This study has been completed.
Sponsor:
Collaborator:
The norwegian association for heart and lung patients
Information provided by:
LHL Helse
ClinicalTrials.gov Identifier:
NCT00249093
First received: November 4, 2005
Last updated: April 12, 2007
Last verified: April 2007

November 4, 2005
April 12, 2007
October 2005
Not Provided
  • dyspnea
  • exercise tolerance
Same as current
Complete list of historical versions of study NCT00249093 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT
Not Provided

The aim of the study is to evaluate effects of supplementary oxygen during exercise on dyspnoea and exercise tolerance in COPD-patients given long-time oxygen treatment

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind
Primary Purpose: Diagnostic
COPD
Drug: oxygen
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
April 2007
Not Provided

Inclusion Criteria:

  • COPD patients (male/female)given long-term oxygen treatment
  • Able to perform two separate walking tests

Exclusion Criteria:

  • Severe heart failure
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT00249093
G25-1
No
Not Provided
LHL Helse
The norwegian association for heart and lung patients
Principal Investigator: Morten S Ryg, dr philos LHL Helse
LHL Helse
April 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP